Abeona Therapeutics Inc Asset Turnover Ratio (ABEO), as of third quarter 2026, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Abeona Therapeutics Inc   (NASDAQ: ABEO)
 

Abeona Therapeutics Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Abeona Therapeutics Inc asset turnover ratio, the ability of Abeona Therapeutics Inc 's assets to generate revenue in the third quarter 2026, increased sequentially to 0.21 in the third quarter (Sep 30 2026), yet the ratio remained below the average, as ABEO's position remain challenging.

Within sector 145 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the Third Quarter 2026 compared to the preceding quarter from 2721 to 3221.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ABEO Asset Turnover Ratio (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Asset Change -18.02 % -20.37 % 99.76 % 106.59 % 93.24 %
Y / Y Revenue Change 706.88 % 697.48 % 669.01 % 581.04 % 40.62 %
Asset Turnover Ratio (TTM) 0.21 0.14 0.09 0.06 0.03
ABEO's Total Ranking # 3221 # 2721 # 2692 # 3449 #
Seq. Asset Change -3.53 % -2.62 % -9.6 % -3.47 % -6.3 %
Seq. Revenue Change 18.55 % 12.96 % 44.6 % 316.69 % 17.17 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 146
Healthcare Sector # 449
Overall Market # 3221

Asset Turnover Ratio Statistics
High Average Low
2.12 0.42 0
(Mar 31 2013)   (Dec 31 2018)




ABEO Company Profile • Back to ABEO Efficiency Comparisons • Compare ABEO Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Sep 30 2026, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Sep 30 2026 Assets at quarter ending Sep 30 2026
Sarepta Therapeutics Inc   0.61 $ 1,956.339  Millions$ 3,220.804  Millions
Heron Therapeutics Inc   0.61 $ 149.458  Millions$ 246.201  Millions
Intuitive Surgical Inc   0.60 $ 12,115.600  Millions$ 20,198.850  Millions
Supernus Pharmaceuticals inc   0.60 $ 865.106  Millions$ 1,444.793  Millions
Baxter International Inc   0.60 $ 11,784.000  Millions$ 19,776.500  Millions
Conmed Corporation  0.59 $ 1,369.288  Millions$ 2,311.365  Millions
Carlsmed Inc   0.59 $ 71.084  Millions$ 120.590  Millions
Bruker Corporation  0.58 $ 3,512.500  Millions$ 6,063.325  Millions
Iqvia Holdings Inc   0.58 $ 17,311.000  Millions$ 29,993.500  Millions
Merit Medical Systems Inc  0.58 $ 1,612.236  Millions$ 2,798.433  Millions
Gilead Sciences Inc   0.57 $ 30,988.000  Millions$ 54,017.750  Millions
Haemonetics Corporation  0.57 $ 1,382.737  Millions$ 2,415.705  Millions
Avantor Inc   0.57 $ 6,635.600  Millions$ 11,670.900  Millions
Bristol myers Squibb Company  0.57 $ 50,033.000  Millions$ 88,230.000  Millions
Rigel Pharmaceuticals Inc  0.56 $ 288.213  Millions$ 515.786  Millions
Stryker Corp  0.56 $ 26,300.000  Millions$ 47,328.000  Millions
Mannkind Corporation  0.55 $ 413.370  Millions$ 747.876  Millions
Icu Medical Inc  0.55 $ 2,183.556  Millions$ 3,994.839  Millions
Emergent Biosolutions Inc   0.55 $ 649.100  Millions$ 1,187.750  Millions
Bionano Genomics Inc   0.54 $ 31.085  Millions$ 58.068  Millions
Integer Holdings Corporation  0.54 $ 1,825.122  Millions$ 3,409.958  Millions
Vanda Pharmaceuticals Inc   0.53 $ 229.278  Millions$ 429.317  Millions
Ge Healthcare Technologies Inc   0.53 $ 19,878.000  Millions$ 37,412.000  Millions
Transmedics Group Inc   0.53 $ 727.650  Millions$ 1,371.382  Millions
Orthopediatrics Corp  0.52 $ 263.665  Millions$ 507.824  Millions
Cryo cell International Inc   0.51 $ 31.127  Millions$ 61.406  Millions
Johnson and Johnson  0.50 $ 99,335.000  Millions$ 199,647.500  Millions
Syndax Pharmaceuticals Inc   0.48 $ 289.431  Millions$ 599.674  Millions
Abbvie Inc   0.48 $ 66,014.000  Millions$ 138,304.500  Millions
Zevra Therapeutics Inc   0.48 $ 140.548  Millions$ 294.899  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.